Those previously classified as morphologic grade 3 astrocytomas would have been treated with radiotherapy alone followed by chemotherapy, while those previously characterised as IDH-mutant glioblastomas would have been treated with concurrent temozolomide-radiotherapy followed by sequential temozolomide. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).